Your browser doesn't support javascript.
loading
Correction to: Clinical value of plasmablasts in predicting disease relapse in patients with IgG4-related disease.
Wang, Yiwen; Zhao, Zheng; Gao, Dai; Wang, Hui; Liao, Simin; Luo, Gui; Ji, Xiaojian; Li, Yan; Wang, Xiuru; Zhao, Yurong; Li, Kunpeng; Zhang, Jie; Jin, Jingyu; Zhang, Yamei; Zhu, Jian; Zhang, Jianglin; Huang, Feng.
Affiliation
  • Wang Y; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Zhao Z; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Gao D; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Wang H; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Liao S; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Luo G; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Ji X; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Li Y; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Wang X; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Zhao Y; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Li K; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Zhang J; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Jin J; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Zhang Y; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Zhu J; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China. jian_jzhu@126.com.
  • Zhang J; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Huang F; Department of Rheumatology and Immunology, First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China. fhuang@301hospital.com.cn.
Clin Rheumatol ; 42(1): 315-317, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36149538
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Rheumatol Year: 2023 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Rheumatol Year: 2023 Type: Article Affiliation country: China